Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.
about
Emerging agents for the prevention of treatment induced neutropenia in adult cancer patients.Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models.Transient co-expression with three -glycosylation enzymes allows production of GalNAc--glycosylated Granulocyte-Colony Stimulating Factor in
P2860
Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.
@en
type
label
Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.
@en
prefLabel
Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.
@en
P2093
P2860
P1433
P1476
Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.
@en
P2093
Ashutosh Pathak
Gisoo Barnes
Lee Schwartzberg
P2860
P2888
P304
P356
10.1007/S12325-014-0133-9
P407
P577
2014-07-03T00:00:00Z
P6179
1012036006